What is the most recent FDA action against Island Kinetics, Inc. d.b.a. CoValence Laboratories?

The most recent FDA event Argus HQ has on file for Island Kinetics, Inc. d.b.a. CoValence Laboratories is dated 2026-04-22, with a severity rating of "high" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Does Argus HQ track new FDA actions for Island Kinetics, Inc. d.b.a. CoValence Laboratories automatically?

Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Island Kinetics, Inc. d.b.a. CoValence Laboratories is observed, this page's event count and history update automatically.

How many FDA actions does Argus HQ track for Island Kinetics, Inc. d.b.a. CoValence Laboratories?

4 total: 0 warning letters, 4 recalls, 0 approval records, and 0 Form 483 inspection citations.

What is the most recent FDA action on file for Island Kinetics, Inc. d.b.a. CoValence Laboratories?

April 22, 2026. Argus HQ ingests new FDA enforcement records daily.

Island Kinetics, Inc. d.b.a. CoValence Laboratories's Complete FDA Record

FDA action counts

Total FDA actions	4
Warning letters	0
Recalls	4
Approval records	0
Form 483 inspection citations	0
Most recent action	April 22, 2026

In short: Argus HQ has recorded 4 FDA events for Island Kinetics, Inc. d.b.a. CoValence Laboratories: 0 warning letters, 4 recalls, 0 approvals, and 0 inspection 483 observations. These events span from 2026-04-22 to 2026-04-22. The most severe rating Argus HQ has assigned across this history is "high". Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Risk pattern analysis

Argus HQ analysis — not an FDA finding

This section is Argus HQ analysis, not an FDA finding. Island Kinetics, Inc. d.b.a. CoValence Laboratories has 4 separate FDA recalls on file, more than a single isolated recall event. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Enforcement history

On 2026-04-22, Argus HQ recorded a FDA recall for Island Kinetics, Inc. d.b.a. CoValence Laboratories, rated "medium" severity in Argus HQ's classification: Island Kinetics, Inc. d.b.a. CoValence Laboratories — Class III recall: Essential Calming Skin Gel, hydrocortisone 1%, 120mL/4oz net wt. (113g) per jar,… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-04-22, Argus HQ recorded a FDA recall for Island Kinetics, Inc. d.b.a. CoValence Laboratories, rated "high" severity in Argus HQ's classification: Island Kinetics, Inc. d.b.a. CoValence Laboratories — Class II recall: Blemish Spot Treatment (Salicylic Acid) 1%, .5 fl oz (15 ml) bottles, Skin Scrip… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-04-22, Argus HQ recorded a FDA recall for Island Kinetics, Inc. d.b.a. CoValence Laboratories, rated "medium" severity in Argus HQ's classification: Island Kinetics, Inc. d.b.a. CoValence Laboratories — Class III recall: Skin Rehab, Calming Skin Gel, Hydrocortisone Balm, hydrocortisone 1%, .53oz net… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-04-22, Argus HQ recorded a FDA recall for Island Kinetics, Inc. d.b.a. CoValence Laboratories, rated "medium" severity in Argus HQ's classification: Island Kinetics, Inc. d.b.a. CoValence Laboratories — Class III recall: Remedy Gel, hydrocortisone 1%, 30 mL/ 1 fl oz per bottle, Distributed By: glo Sk… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. In total, Island Kinetics, Inc. d.b.a. CoValence Laboratories has 4 FDA events on file with Argus HQ across the sources Argus HQ currently tracks (FDA Warning Letters, recalls, drug/biologic approvals, and Form 483 inspection observations).

Frequently asked questions

What is the most recent FDA action against Island Kinetics, Inc. d.b.a. CoValence Laboratories?: The most recent FDA event Argus HQ has on file for Island Kinetics, Inc. d.b.a. CoValence Laboratories is dated 2026-04-22, with a severity rating of "high" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
Does Argus HQ track new FDA actions for Island Kinetics, Inc. d.b.a. CoValence Laboratories automatically?: Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Island Kinetics, Inc. d.b.a. CoValence Laboratories is observed, this page's event count and history update automatically.
How many FDA actions does Argus HQ track for Island Kinetics, Inc. d.b.a. CoValence Laboratories?: 4 total: 0 warning letters, 4 recalls, 0 approval records, and 0 Form 483 inspection citations.
What is the most recent FDA action on file for Island Kinetics, Inc. d.b.a. CoValence Laboratories?: April 22, 2026. Argus HQ ingests new FDA enforcement records daily.

Every FDA action tied to this company, the week it happens.

Free weekly briefing. Real-time alerts on paid plans.

Compare with

Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2026). Island Kinetics, Inc. d.b.a. CoValence Laboratories's Complete FDA Record. Digital Empire LLC. Retrieved from https://argushq.ai/company/island-kinetics-inc-d-b-a-covalence-laboratories

MLA

"Island Kinetics, Inc. d.b.a. CoValence Laboratories's Complete FDA Record." Argus HQ Research, Digital Empire LLC, 2026, argushq.ai/company/island-kinetics-inc-d-b-a-covalence-laboratories.

Chicago

Argus HQ Research. "Island Kinetics, Inc. d.b.a. CoValence Laboratories's Complete FDA Record." Digital Empire LLC. Accessed July 13, 2026. https://argushq.ai/company/island-kinetics-inc-d-b-a-covalence-laboratories.

BibTeX

@misc{argushq_argushq_ai_company_island_kinetics_inc_d_b_a_covalence_laboratories_2026,
  title = {Island Kinetics, Inc. d.b.a. CoValence Laboratories's Complete FDA Record},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire LLC},
  url = {https://argushq.ai/company/island-kinetics-inc-d-b-a-covalence-laboratories},
  note = {Accessed: July 13, 2026}
}

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗